PTC Therapeutics to sell priority review voucher for 150M
EMCCX Fund | USD 59.75 0.05 0.08% |
Slightly above 55% of Empiric 2500's investor base is interested to short. The analysis of overall sentiment of trading Empiric 2500 Fund mutual fund suggests that many investors are impartial at this time. Empiric 2500's investing sentiment can be driven by a variety of factors including economic data, Empiric 2500's earnings reports, geopolitical events, and overall market trends.
Empiric |
PTC Therapeutics sells Rare Pediatric Disease Priority Review Voucher for 150 million after FDA approval of KEBILIDI for AADC deficiency.
Read at seekingalpha.com
Empiric 2500 Fundamental Analysis
We analyze Empiric 2500's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Empiric 2500 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Empiric 2500 based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Position Weight
Cash Position Weight Comparative Analysis
Empiric 2500 is currently under evaluation in cash position weight among similar funds. Percentage of fund asset invested in cash equivalents or risk-free instruments. About 40% of all global funds carry cash on their balance sheet.
Empiric 2500 Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Empiric 2500 mutual fund to make a market-neutral strategy. Peer analysis of Empiric 2500 could also be used in its relative valuation, which is a method of valuing Empiric 2500 by comparing valuation metrics with similar companies.
Peers
Empiric 2500 Related Equities
JRI | Nuveen Real | 1.49 | ||||
VIGAX | Vanguard Growth | 0.79 | ||||
VFINX | Vanguard 500 | 0.57 | ||||
FBALX | Fidelity Balanced | 0.49 | ||||
NBGIX | Neuberger Berman | 0.18 | ||||
DFMGX | Df Dent | 0.10 | ||||
EMCAX | Empiric 2500 | 0.07 | ||||
FHCOX | Federated Hermes | 0.00 | ||||
FIKHX | Fidelity Advisor | 1.13 |
Other Information on Investing in Empiric Mutual Fund
Empiric 2500 financial ratios help investors to determine whether Empiric Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Empiric with respect to the benefits of owning Empiric 2500 security.
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |